Marius M. Hoeper
0000-0001-9086-2293
Publication & Citation Trends
Publications
0 total
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies
Cited by 1
Semantic Scholar
Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
Cited by 0
Semantic Scholar
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis OA
Cited by 3
Semantic Scholar
Corrigendum to ''Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials'' [The Journal of Heart and Lung Transplantation, 44 (2025) 135-146].
Cited by 0
Semantic Scholar
Efficacy and Safety of Sotatercept Across Ranges of Cardiac Index in Patients with Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR.
Cited by 8
Semantic Scholar
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension OA
Cited by 12
Semantic Scholar
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study
Cited by 18
Semantic Scholar
Pulmonary hypertension in heart failure: the good, the bad, and the ugly. OA
Cited by 3
Semantic Scholar
Research Topics
Pulmonary Hypertension Research and Treatments
(612)
Cardiovascular Issues in Pregnancy
(127)
Heart Failure Treatment and Management
(90)
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
(86)
Cardiovascular Function and Risk Factors
(84)
Affiliations
Université Paris-Sud
Leibniz University Hannover
University of Minnesota
Hochschule Hannover
Inserm